Literature DB >> 28489273

Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: A randomized controlled study.

Samia M Esmat1, Rehab A Hegazy1, Heba I Gawdat1, Rania M Abdel Hay1, Riham S Allam2, Rofaida El Naggar1, Hoda Moneib3.   

Abstract

BACKGROUND: Female pattern hair loss (FPHL) is the most common form of hair loss in women. Nevertheless, its management represents a real challenge. Among the FDA approved therapeutic modalities for FPHL are topical minoxidil and more recently low-level light therapy (LLLT). AIM OF WORK: Assess the efficacy and safety of LLLT in comparison to topical minoxidil 5% and to a combination of both therapies in the treatment of FPHL. PATIENTS AND METHODS: This study included 45 female patients with proven FPHL. They were randomly divided into three equal groups, where group (i) patients were instructed to apply topical minoxidil 5% twice daily, group (ii) patients received LLLT using the helmet iGrow® device for 25 minutes 3 days weekly, and group (iii) patients received a combination of both topical minoxidil 5% twice daily and LLLT for 25 minutes 3 days weekly for 4 months (study duration). Evaluation was done according to clinical, dermoscopic (folliscopic), and ultrasound bio-microscopic (UBM) parameters. Patient satisfaction and side effects were reported.
RESULTS: The efficacy and safety of both topical minoxidil and LLLT were highlighted with comparable results in all parameters. The combination group (iii) occupied the top position regarding Ludwig classification and patient satisfaction. UBM and dermoscopic findings showed significant increase in the number of regrowing hair follicles at 4 months in all groups, whereas only UBM showed such significant increase at 2 months in the combination group (iii). A non-significant increase in the hair diameter was also documented in the three groups.
CONCLUSION: LLLT is an effective and safe tool with comparable results to minoxidil 5% in the treatment of FPHL. Owing to the significantly better results of combination therapy, its usage is recommended to hasten hair regrowth. Lasers Surg. Med. 49:835-843, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  UBM; dermoscope; female pattern hair loss; low light laser therapy; minoxidil

Mesh:

Substances:

Year:  2017        PMID: 28489273     DOI: 10.1002/lsm.22684

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  10 in total

Review 1.  Low-level laser therapy for the treatment of androgenic alopecia: a review.

Authors:  Evan Darwin; Alexandra Heyes; Penelope A Hirt; Tongyu Cao Wikramanayake; Joaquin J Jimenez
Journal:  Lasers Med Sci       Date:  2017-12-21       Impact factor: 3.161

Review 2.  Review of quality of life studies in women with alopecia.

Authors:  D S Davis; V D Callender
Journal:  Int J Womens Dermatol       Date:  2018-01-09

Review 3.  Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair Loss: A Review of the Literature.

Authors:  Andjela Egger; Sydney R Resnik; Divya Aickara; Eric Maranda; Michael Kaiser; Tongyu C Wikramanayake; Joaquin J Jimenez
Journal:  Skin Appendage Disord       Date:  2020-07-07

4.  A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.

Authors:  Suparuj Lueangarun; Poom Visutjindaporn; Yardnapar Parcharoen; Pollawat Jamparuang; Therdpong Tempark
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

5.  Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials.

Authors:  Kao-Hui Liu; Donald Liu; Yu-Tsung Chen; Szu-Ying Chin
Journal:  Lasers Med Sci       Date:  2019-01-31       Impact factor: 3.161

6.  Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity.

Authors:  Yann F Mahe; Ahsène Cheniti; Charlotte Tacheau; Rosaria Antonelli; Lien Planard-Luong; Simon de Bernard; Laurent Buffat; Philippe Barbarat; Leila Kanoun-Copy
Journal:  Lasers Surg Med       Date:  2021-05-11

Review 7.  Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.

Authors:  Mark S Nestor; Glynis Ablon; Anita Gade; Haowei Han; Daniel L Fischer
Journal:  J Cosmet Dermatol       Date:  2021-11-06       Impact factor: 2.189

8.  Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives.

Authors:  Michael R Hamblin
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-06

Review 9.  Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia.

Authors:  Jisha K Pillai; Venkataram Mysore
Journal:  J Cutan Aesthet Surg       Date:  2021 Oct-Dec

10.  Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia.

Authors:  Doris Day; Madison McCarthy; Iva Talaber
Journal:  J Cosmet Dermatol       Date:  2021-08-26       Impact factor: 2.189

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.